MediciNova, Inc. (MNOV) vs PMV Pharmaceuticals, Inc. (PMVP)

A side-by-side comparison of MediciNova, Inc. and PMV Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MNOV vs PMVP

growth of $100 · dividends reinvested · last 6y
MNOV -68.2% (-17.4%/yr)PMVP -95.3% (-39.8%/yr)MNOV compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$32$5
MNOV PMVP

MNOV vs PMVP: by the numbers

  • •PMVP is the larger company ($86M vs $81M market cap).
  • •Both run net losses; PMVP's is the smaller (0.00% vs -1168.20% net margin).

Metrics side by side

Valuation

MetricMNOVPMVP
P/S ratio88.23N/A
P/B ratio2.181.20

Profitability

MetricMNOVPMVP
Gross margin7.58%0.00%
Operating margin-3242.47%0.00%
Net margin-1168.20%0.00%
ROE-28.85%-105.20%
ROIC-31.62%-111.42%

Growth (annualized)

MetricMNOVPMVP
Revenue CAGR (5Y)-25.46%N/A
Total return CAGR (5Y)-13.62%-43.17%

Frequently asked

How have MNOV and PMVP total returns compared?
Over the past 5 years, MNOV delivered -13.62% and PMVP delivered -43.17% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.